Quantitative analysis of interferon α/β receptor mRNA in the liver of patients with chronic hepatitis C: Correlation with serum hepatitis C virus- RNA levels and response to treatment with interferon

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 6, 1997, Pages 460-467

  Yatsuhashi, Hiroshi ^a,b   Yamasaki, Kazumi ^a   Aritomi, Tomoyuki ^a   Del Carmen, Parquet Maria ^a   Inoue, Osami ^a   Koga, Michiaki ^a   Yano, Michitami ^a  

^a National Hospital Organization   (Japan)

^b Institute for Clinical Research Nagasaki Chuo National Hospital WHO Collaborating Ctr Ref Res V   (Japan)

Author keywords

chronic hepatitis C; HCV RNA level; interferon; interferon receptor gene

Indexed keywords

ALPHA INTERFERON; INTERFERON RECEPTOR; LYMPHOBLAST INTERFERON; VIRUS RNA;

ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

EID: 0030957052     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00467.x     Document Type: Article

References (26)

1. Shindo M, Di Bisceglie AM, Hoofnagle JH. Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon. Hepatology 1992; 15: 1013-16.
2. Yatsuhashi H, Inoue O, Inokuchi K et al. Short and long-term effects of interferon on serum markers of hepatitis C virus replication. J. Gastroenterol. Hepatol. 1993; 8: 1-6.
3. Poynard T, Leroy V, Cohard M et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration. Hepatology 1996; 24: 778-89.
4. Lin R, Roach E, Zimmerman M, Strasser S, Farrel G. Interferon alfa-2b for chronic hepatitis C: Effects of dose increment and duration of treatment on response rates. J. Hepatol. 1995; 23: 487-96.
5. Hagiwara H, Hayashi N, Mita E et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy. Gastroenterology 1993; 104: 877-83.
6. Lau JYN, Davis GL, Kniffen J et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501-4.
7. Inokuchi K, Yatsuhashi H, Inoue O, Koga M, Nagataki S, Yano M. Correlation of quantitative HCV-RNA levels using a branched DNA enhanced level amplification assay with therapeutic effects of β-interferon in patients with chronic hepatitis C. Int. Hepatol. Commun. 1994; 2: 375-82.
8. Uze G, Lutfalla G, Gresser I. Genetic transfer of a functional human interferon a receptor into mouse cells: Cloning and expression of its cDNA. Cell 1990; 60: 225-34.
9. Novick D, Cohen B, Rubinstein M. The human interferon-α/β receptor: Characterization and molecular cloning. Cell 1994; 77: 391-400.
10. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate phenolchloroform extraction. Anal. Biochem. 1987; 162: 156-9.
12. Innis MA, Gelfand DH, Sninsky J, White TJ. PCR protocol: A guide to method and application. New York: Academic Press, 1990.
13. Iijima SN, Hamada H, Reddy P, Kakunaga T. Molecular structure of the human cytoplasmic β-actin gene: Interspecies homology of sequences in the introns. Proc. Natl Acad. Sci. USA 1985; 82: 6133-7.
14. Kinoshita T, Imamura J, Nagai H, Shimotohno K. Quantification of gene expression over a wide range by the polymerase chain reaction. Anal. Biochem. 1992; 206: 231-5.
15. Wang AM, Doyle MV, Mark DF. Quantification of mRNA by the polymerase chain reaction. Proc. Natl Acad. Sci. USA 1989; 86: 9717-21.
16. Gilliland G, Perrin S, Blanchard K, Bunn HF. Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction. Proc. Natl Acad. Sci. USA 1990; 87: 2725-9.
17. Ioue K, Sugiyama H, Ogawa H et al. Expression of interleukin-6 (IL-6), IL-6 receptor and gp130 genes in acute leukemia. Blood 1994; 84: 2672-80.
18. Larrea E, Garcia N, Qian C, Civeira MP, Prieto J. Enhanced expression of TNFa in patients with primary biliary cirrhosis. Int. Hepatol. Commun. 1994; 2: 6-13.
19. Roulot D, Durand H, Coste T et al. Quantitative analysis of transforming growth factor β1 messenger RNA in the liver of patients with chronic hepatitis C: Absence of correlation between high levels and severity of disease. Hepatology 1995; 21: 298-304.
20. De Alava E, Camps J, Pardo-Mindam J et al. Histological outcome of chronic hepatitis C treated with a 12-month course of lymphoblastoid alpha interferon. Liver 1993; 13: 73-9.
21. Pagliaro L, Craxi A, Cammaa C et al. Interferon-alpha for chronic hepatitis C: An analysis of pretreatment clinical predictors of response. Hepatology 1994; 19: 820-8.
22. Ishimura N, Fukuda R, Fukumoto S. Relationship between intrahepatic expression of interferon-α receptor mRNA and the histological progress of hepatitis C virus-associated chronic liver diseases. J. Gastroenterol. Hepatol. 1996; 11: 712-17.
23. Sata M, Miyajima I, Suzuki H, Ueno T, Tanikawa K. Interferon therapy in patients with HCV related liver cirrhosis. Frontiers in Hepatology 94. Tokyo: Axel Springer Japan, 1994.
24. Miyajima I, Sata M, Gondo K, Suzuki H, Tanigawa K. Interferon accumulation in cirrhotic rat liver. J. Viral Hepatitis 1996; 3: 23-7.
25. Chemello L, Bonetti P, Cavalletto L et al. Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. Hepatology 1995; 22: 700-6.
26. Martinot-Peignoux M, Marcellin P, Pouteau M et al. Pretreatment serum HCV-RNA levels and HCV genotype are the main and independent prognostic factors of sustained response to alpha interferon therapy in chronic hepatitis C. Hepatology 1995; 22: 1050-6.